Acute kidney injury (AKI) is an important health problem, affecting 13.3 million individuals/year. It is associated with increased mortality, mainly in low- and middle-income countries, where renal replacement therapy is limited. Moreover, survivors show adverse long-term outcomes, including increased risk of developing recurrent AKI bouts, cardiovascular events, and chronic kidney disease. However, there are no specific treatments to decrease the adverse consequences of AKI. Epidemiological and preclinical studies show the pathological role of inflammation in AKI, not only at the acute phase but also in the progression to chronic kidney disease. Toll-like receptors (TLRs) are key regulators of the inflammatory response and have been associated to many cellular processes activated during AKI. For that reason, a number of anti-inflammatory agents targeting TLRs have been analyzed in preclinical studies to decrease renal damage during AKI. In this review, we updated recent knowledge about the role of TLRs, mainly TLR4, in the initiation and development of AKI as well as novel compounds targeting these molecules to diminish kidney injury associated to this pathological condition.
Embryonic megakaryopoiesis starts in the yolk sac on gestational day 7.5 as part of the primitive wave of hematopoiesis, and it continues in the fetal liver when this organ is colonized by hematopoietic progenitors between day 9.5 and 10.5, as the definitive hematopoiesis wave. We characterized the precise phenotype of embryo megakaryocytes in the liver at gestational day 11.5, identifying them as CD41++CD45-CD9++CD61+ MPL+CD42c+ tetraploid cells that express megakaryocyte-specific transcripts and display differential traits when compared to those present in the yolk sac at the same age. In contrast to megakaryocytes from adult bone marrow, embryo megakaryocytes are CD45- until day 13.5 of gestation, as are both the megakaryocyte progenitors and megakaryocyte/erythroid-committed progenitors. At gestational day 11.5, liver and yolk sac contain also CD41+CD45+ and CD41+CD45- cells. These populations, and that of CD41++CD45-CD42c+ cells isolated from liver differentiate in culture into CD41++CD45-CD42c+ proplatelet-bearing megakaryocytes. Also present at this time are CD41-CD45++CD11b+ cells, which produce low numbers of CD41++CD45-CD42c+ megakaryocytes in vitro, as do fetal liver cells expressing the macrophage-specific Csf Receptor-1 (Csf1r/CD115) from MaFIA transgenic mice, which poorly give rise to CD41++CD45-CD42c+ embryo megakaryocytes both in vivo and in vitro. In contrast, around 30% of adult megakaryocytes (CD41++CD45++CD9++CD42c+) from C57BL/6 and MaFIA mice express CD115. We propose that differential pathways operating in the mouse embryo liver at gestational day 11.5 beget CD41++CD45-CD42c+ embryo megakaryocytes that can be produced from CD41+CD45- or from CD41+CD45+ cells, at difference to those from bone marrow.
15 October 2024 in Free Radical Biology and Medicine
Massive intravascular hemolysis occurs not unfrequently in many clinical conditions. Breakdown of erythrocytes promotes the accumulation of heme-derivates in the kidney, increasing oxidative stress and cell death, thus promoting acute kidney injury (AKI). NADPH oxidase 4 (Nox4) is a major source of reactive oxygen species (ROS) in the kidney, however it is unknown the role of Nox4 in hemolysis and whether inhibition of this enzyme may protect from heme-mediated injury. To answer these questions, we elicited intravascular hemolysis in wild type and Nox4 knockout mice. We also evaluated whether nephrotoxic effects of heme may be reduced by using Nox4 siRNA and pharmacologic inhibition with GKT137831, a Nox4 inhibitor, both in vivo and in cultured renal cells. Our results showed that induction of massive hemolysis elicited AKI characterized by loss of renal function, morphological alterations of the tubular epithelium and podocytes, oxidative stress, inflammation, mitochondrial dysfunction, blockade of autophagy and cell death. These pathological effects were significantly prevented in Nox4-deficient mice and in animals treated with GKT137831. In vitro studies showed that Nox4 disruption by specific siRNAs or Nox4 inhibitors declined heme-mediated ROS production and cell death. Our data identify Nox4 as a key enzyme involved in intravascular hemolysis-induced AKI. Thus, Nox4 inhibition may be a potential therapeutic approach to prevent renal damage in patients with severe hemolytic crisis.
CD5 and CD6 are signal transducing type I transmembrane scavenger receptors mediating recogni-tion of host and microbial ligands. They are mainly expressed by all T cells, but also a small subset of B cells for which limited information is still available. Here we evaluated the impact of CD5 and CD6 deficiency on B1 and innate-like B cell populations in spleen and peritoneum compared to wild-type BL6 mice and Btk-deficient CBA/N mice. Both CD5- (Cd5-/-) and CD6 (Cd6-/-)-deficient mice showed decreased B1 cells (B220loCD11b+) in the spleen, as well as in peritoneal exudate. By contrast, B220loCD11b- (B220lo) cells were reduced in Cd5-/- mice from the neonatal stage, while remaining similar to BL6 levels in Cd6-/- mice. Transcriptomic analysis of purified B220lo cells revealed a con-served core program across wild-type, Cd5-/-and Cd6-/-strains, with reduced BCR co-receptor and Ras signalling, alongside increased pathways related to activation, transcriptional regulation, and im-mune modulation. Genotype-specific divergences were found, consisting of CD5 deficiency pro-moting a more structured and regulated signalling state, while CD6 deficiency induced a highly activated and metabolically reprogrammed phenotype, with increased mitochondrial activity, redox balance, biosynthetic capacity and reduced dependence on interferon-mediated signalling. Collec-tively, these findings identify B220lo B cells as a flexible population whose functional polarization is differentially controlled by CD5- and CD6-dependent regulatory axes governing signalling organi-zation and metabolic activation.
30 November 2023 in Revista de Investigación y Educación en Ciencias de la Salud (RIECS)
El término inmunología, derivado del latín “immunitas”, aparece en algunos escritos griegos refiriéndose a aquellos individuos libres de padecer una enfermedad debido a que previamente ya la habían sufrido. Desde estas primeras observaciones hasta la fecha las investigaciones en esta área del conocimiento no han dejado de aportar nuevos hallazgos, siempre con el objetivo de conseguir entender la enfermedad para finalmente tratarla o prevenirla. En este momento nuevos conceptos como la inmunidad entrenada, la vacunología inversa o las células CAR-T junto con los avances tecnológicos se abren paso para continuar avanzando en el conocimiento del sistema inmunitario.
Previously, we identified a stabilization of the HIV reservoir size in HIV + monoinfected and HIV+/HCV + coinfected patients who eliminated HCV with DAAs as well as a decrease in HIV reservoir size in HIV+/HCV- spontaneously clearers. However, variations in the distribution of memory CD4 + T cell subpopulations in coinfected patients after HCV clearance remains unclear. To analyze the expression pattern of T cell maturation (CD45RA and CD27) and senescence (CD28 and CD57) markers by flow cytometry in those patients. Longitudinal study (52 weeks follow-up) of 49 HIV+/HCV+, 38 HIV+/HCV- and 59 HIV + subjects, all of them aviremic. A generalized increase in expression of CD28 was observed for CD8 + and in CD4 + CD27 + cells. The proportion of both CD4 + TEM TH1 and TH2 cells decreased significantly in HIV+/HCV- while remained stable in HIV + and HIV+/HCV + individuals. The general decline in cell senescence of cytotoxic lymphocytes may be due to reduced antigenic stimulation of HIV-specific and HCV-specific lymphocytes. The dynamic of HIV viral reservoir in HIV+/HCV- patients matches the dynamic of CD4 + cells with a TH1 phenotype, which could mean a decrease in the number of circulating TFH1 lymphocytes after an improvement in generalized inflammation state.